| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Target of rapamycin complex 2 subunit MAPKAP1 |
|---|
| Ligand | BDBM50606733 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2261205 (CHEMBL5216216) |
|---|
| IC50 | 2.2±n/a nM |
|---|
| Citation |  Oleksak, P; Nepovimova, E; Chrienova, Z; Musilek, K; Patocka, J; Kuca, K Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021). Eur J Med Chem238:0 (2022) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Target of rapamycin complex 2 subunit MAPKAP1 |
|---|
| Name: | Target of rapamycin complex 2 subunit MAPKAP1 |
|---|
| Synonyms: | MAPKAP1 | MIP1 | Mitogen-activated protein kinase 2-associated protein 1 | SAPK-interacting protein 1 | SIN1 | SIN1_HUMAN | Stress-activated map kinase-interacting protein 1 | TORC2 subunit MAPKAP1 | Target of rapamycin complex 2 subunit MAPKAP1 | mSIN1 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 59129.70 |
|---|
| Organism: | Homo sapiens |
|---|
| Description: | ChEMBL_119716 |
|---|
| Residue: | 522 |
|---|
| Sequence: | MAFLDNPTIILAHIRQSHVTSDDTGMCEMVLIDHDVDLEKIHPPSMPGDSGSEIQGSNGE
TQGYVYAQSVDITSSWDFGIRRRSNTAQRLERLRKERQNQIKCKNIQWKERNSKQSAQEL
KSLFEKKSLKEKPPISGKQSILSVRLEQCPLQLNNPFNEYSKFDGKGHVGTTATKKIDVY
LPLHSSQDRLLPMTVVTMASARVQDLIGLICWQYTSEGREPKLNDNVSAYCLHIAEDDGE
VDTDFPPLDSNEPIHKFGFSTLALVEKYSSPGLTSKESLFVRINAAHGFSLIQVDNTKVT
MKEILLKAVKRRKGSQKVSGPQYRLEKQSEPNVAVDLDSTLESQSAWEFCLVRENSSRAD
GVFEEDSQIDIATVQDMLSSHHYKSFKVSMIHRLRFTTDVQLGISGDKVEIDPVTNQKAS
TKFWIKQKPISIDSDLLCACDLAEEKSPSHAIFKLTYLSNHDYKHLYFESDAATVNEIVL
KVNYILESRASTARADYFAQKQRKLNRRTSFSFQKEKKSGQQ
|
|
|
|---|
| BDBM50606733 |
|---|
| n/a |
|---|
| Name | BDBM50606733 |
|---|
| Synonyms: | CHEMBL5218988 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C18H22N6O |
|---|
| Mol. Mass. | 338.4069 |
|---|
| SMILES | CC(C)CC1(C)CN(c2c1ncnc2N)c1ccc2oc(N)nc2c1 |
|---|
| Structure | 
|
|---|
Search and Browse
